EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Blood pressure parameters and cognitive decline and dementia after stroke or transient ischemic attack: results from the PROGRESS trial

Sultana Shajahan iD, Mark Woodward iD, Craig S Anderson iD, Cheryl Carcel iD, Linan Chen iD, Ruth Peters iD, Karin Rådholm iD, Stephen Harrap iD, John Chalmers iD, Katie Harris iD

American Journal of Hypertension · 01.09.2026 · 39 (9) · 1151-1159

DOI: 10.1093/ajh/hpag056 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift American Journal of Hypertension, online erschienen am 19.06.2026. Verfasst von Sultana Shajahan und 9 weiteren Autor:innen. Beteiligte Einrichtung: The George Institute for Global Health, The University of New South Wales, Sydney, Australia. Hauptthemen laut MEDLINE: Dementia, Stroke, Cognitive Dysfunction, Ischemic Attack, Transient. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Council of New Zealand, Australian National Health and Medical Research Council, University of New South Wales.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Besides elevated mean systolic blood pressure (BP), BP variability, pulse pressure (PP), or mean arterial pressure (MAP) could be important targets for dementia prevention. This study investigated these associations in participants with stroke or transient ischemic attack from the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) trial.

Methods

BP parameters were calculated from measurements for 18 months on six occasions. Risk of cognitive decline according to Mini-Mental State Examination scores and/or adjudicated dementia outcomes per 1-standard deviation higher for each BP parameter was calculated using modified Poisson regression models with a log link. Subgroup analysis was conducted by mild cognitive impairment (MCI) at baseline, sex, and stroke subtype.

Results

Of 5128 participants recruited between May 1995 and November 1997, 567 (11.1%) developed cognitive decline/dementia after 4 (median) years of follow-up until 2001. For systolic BP (SBP), higher mean, maximum, cumulative load, and last measure were associated with higher risk of cognitive decline/dementia, but mean conferred the highest risk (relative risk 1.18, 95% confidence intervals [CIs] 1.06-1.31). For diastolic BP, higher mean, maximum, variability, cumulative load, slope, and last measure were associated, while load showed the strongest association (1.23, 95% CI 1.12-1.36). Only the mean PP was associated (1.11, 95% CI 1.00-1.24). For MAP, MAP load showed the strongest association (1.20, 95% CI 1.09-1.33). Systolic, diastolic, and MAP variability showed a higher risk in those without MCI.

Conclusions

Besides mean SBP, higher variability, cumulative load, slope, and last measures of diastolic BP, PP, and MAP were associated with increased risk of cognitive decline/dementia. Clinical Trial Registration This trial was not registered because enrollment began before July 1, 2005.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DementiaStrokeCognitive DysfunctionIschemic Attack, TransientBlood PressureCognitionHypertensionHumansFemaleMaleAgedRisk FactorsAntihypertensive AgentsPerindoprilMiddle AgedTime Factors

Stichwörter der Autor:innen

blood pressurecognitive declinedementiapulse pressurestroke

Substanzen

Antihypertensive AgentsPerindopril

Autor:innen und Institutionen

  • The George Institute for Global Health, The University of New South Wales, Sydney, Australia.
  • The George Institute for Global Health, Imperial College London, London, United Kingdom.
  • Institute of Science and Technology for Brain-inspired Intelligence, Fudan University, Shanghai, China.
  • Neurology Department, Royal Prince Alfred Hospital, Sydney, Australia.
  • Prince of Wales Clinical School, The University of New South Wales, Sydney, Australia.
  • Department of Health, Medicine, and Caring Sciences, Linköping University, Linköping, Sweden.

ORCID-Profile: Sultana Shajahan, Mark Woodward, Craig S Anderson, Cheryl Carcel, Linan Chen, Ruth Peters, Karin Rådholm, Stephen Harrap, John Chalmers, Katie Harris

Förderung

  • Health Research Council of New Zealand
  • Australian National Health and Medical Research Council
  • University of New South Wales
  • The George Institute for Global Health
  • NHMRC
  • MRF_
  • AstraZeneca
  • Heart Foundation Vanguard

Zitieren

APA

Shajahan, S., Woodward, M., Anderson, C. S., Carcel, C., Chen, L., Peters, R., Rådholm, K., Harrap, S., Chalmers, J., & Harris, K. (2026). Blood pressure parameters and cognitive decline and dementia after stroke or transient ischemic attack: results from the PROGRESS trial. American Journal of Hypertension, 39(9), 1151-1159. https://doi.org/10.1093/ajh/hpag056

Vancouver

Shajahan S, Woodward M, Anderson CS, Carcel C, Chen L, Peters R, et al. Blood pressure parameters and cognitive decline and dementia after stroke or transient ischemic attack: results from the PROGRESS trial. American Journal of Hypertension. 2026;39(9):1151-1159. doi:10.1093/ajh/hpag056

BibTeX
@article{Shajahan2026,
  author = {Shajahan, Sultana and Woodward, Mark and Anderson, Craig S and Carcel, Cheryl and Chen, Linan and Peters, Ruth and Rådholm, Karin and Harrap, Stephen and Chalmers, John and Harris, Katie},
  title = {Blood pressure parameters and cognitive decline and dementia after stroke or transient ischemic attack: results from the PROGRESS trial},
  journal = {American Journal of Hypertension},
  year = {2026},
  volume = {39},
  number = {9},
  pages = {1151--1159},
  doi = {10.1093/ajh/hpag056}
}
Kostenlos starten →